Valo Health launched in September with $100 million and a couple of acquisitions under its belt to transform drug development and trim years off R&D timelines. Now, it’s topping up its coffers with $110 million from Koch Disruptive Technologies that will bankroll the development of its technology as well as the discovery and development of its drug programs.
The investment will be used to bring the new levels of scale, speed and cost effectiveness promised by Pliops’ storage processor to more customers in more ways. A hardware-enabled storage engine deployed in a PCIe card form factor or as a cloud service, the storage processor unlocks the full potential of SSD storage by exponentially improving cost, performance and endurance. Through its storage processor, Pliops substantially accelerates the processing of data-intensive applications in data centers.
